A study of outpatient treatment for opioid addiction finds white patients are almost 35 times more likely than black patients to have a visit related to the addiction treatment medication buprenorphine, Kaiser Health News reports.
A federal appeals court has ruled a Maine jail must provide an incarcerated woman with medications for her opioid use disorder, NPR report. The decision could have wide repercussions, according to legal advocates.
Making the opioid addiction medication buprenorphine more widely available outweighs the risk the drug will be diverted, addiction experts tell NPR. President Trump is expected to sign a bill that would increase access to the medication.
Researchers at New York University are studying whether providing the opioid-addiction medicine extended-release naltrexone (Vivitrol) to individuals when they leave jail reduces their risk of relapse and overdose.